Skip to content

Lifevantage Corporation LFVN Protandim — Revenue

Other product segments

True Science Product Line
$8.89M-24.0%
Life Vantage Product Line
$6.32M-61.2%
AXIO Product Line
$3.43M-11.9%
Love Biome Product Line
$3.18M
Phys IQ Product Line
$847K-37.9%
Petandim Product Line
$466K-15.7%

Similar metrics at other companies

Nuvation Bio logo
NUVBProduct Revenue — Revenue
$18.5M+2,213%
AnaptysBio, Inc. logo
ANABAnaptys Bio Generated Anti PD1Jemperli Dostarlimab — Revenue
$258M
Lantheus Holdings logo
LNTHProduct — Revenue
$369.85M+0.8%
Tactile Systems Technology logo
TCMDProduct — Revenue
$66.97M+27.6%
LQD
LQDAProduct — Revenue
$129.88M
PTC Therapeutics logo
PTCTProduct — Revenue
$225.57M+47.0%

Other financials

Income statement

See full
Revenue$43.7M-25.2%
Gross profit$34.5M-27.0%
Operating income$1.7M-58.6%
Net income$1.4M-60.7%
EPS (diluted)$0.11-57.7%

Balance sheet

See full
Cash & equivalents$12.5M-44.4%
Total debt$10.2M-17.4%
Total equity$33.3M-2.0%
Total assets$62.1M-19.6%

Cash flow

See full
Operating cash flow$5.0M+124%
CapEx$1.0M+205%
Free cash flow$4.0M+110%

Valuation

See full
Market cap$78.72M-51.3%
Enterprise value$76.45M-50.0%
P/E13.7×-2.8×
P/S0.4×-0.3×

Profitability

See full
Gross margin78.1%-2.2pp
Operating margin3.4%-2.5pp
Net margin2.9%-1.2pp
FCF margin3.8%+1.1pp

Returns & leverage

See full
Return on equity17.1%-13.0pp
Debt / equity0.3×-0.1×
Current ratio+0.3×

Where this comes from

Reported directly by Lifevantage Corporation in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Lifevantage Corporation’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Lifevantage Corporation's protandim — revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Lifevantage Corporation's protandim — revenue?
Lifevantage Corporation (LFVN) reported protandim — revenue of $19.95M in Q1 2026.
How has Lifevantage Corporation's protandim — revenue changed year-over-year?
Lifevantage Corporation's protandim — revenue decreased by 15.1% year-over-year, from $23.5M to $19.95M.
What is the long-term trend for Lifevantage Corporation's protandim — revenue?
Over 3 years (2022 to 2025), Lifevantage Corporation's protandim — revenue has grown at a -11.1% compound annual growth rate (CAGR), from $135.62M to $95.33M.
What does protandim — revenue mean?
This metric represents the total net revenue generated from the sale of the Protandim product line, excluding any sales-related taxes collected from customers. It serves as a key indicator of the market demand and commercial performance for the company's flagship nutraceutical dietary supplement. Tracking this revenue stream helps investors assess the product's contribution to overall top-line growth and its lifecycle stage within the company's broader health and wellness portfolio.